BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karathanos C, Nana P, Spanos K, Kouvelos G, Brotis A, Matsagas M, Giannoukas A. Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: a systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord 2021:S2213-333X(21)00212-2. [PMID: 33965611 DOI: 10.1016/j.jvsv.2021.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Oleksiuk-bójko M, Lisowska A. Venous thromboembolism: Why is it still a significant health problem? Advances in Medical Sciences 2023;68:10-20. [DOI: 10.1016/j.advms.2022.10.002] [Reference Citation Analysis]
2 Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation 2023;147:e93-e621. [PMID: 36695182 DOI: 10.1161/CIR.0000000000001123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 McLeod B, Lim HY, Nandurkar H, Ho P, Wang J. Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis. Diagnostics (Basel) 2022;12. [PMID: 36553172 DOI: 10.3390/diagnostics12123165] [Reference Citation Analysis]
4 Dong Q, Zhu X, Gao Y, Wang Z, Zheng D, Zhu J, Zheng P. Analysis of the Preventive Action of Rivaroxaban against Lower Extremity Deep Venous Thrombosis in Patients after Laparoscopic Radical Gastrectomy. Computational and Mathematical Methods in Medicine 2022;2022:1-6. [DOI: 10.1155/2022/7140066] [Reference Citation Analysis]
5 Rinfret F, Gu CS, Vedantham S, Kahn SR. New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial. Res Pract Thromb Haemost 2022;6:e12796. [PMID: 36051541 DOI: 10.1002/rth2.12796] [Reference Citation Analysis]
6 Delluc A, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Rodger MA. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled trial (SAVER). Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.03.014] [Reference Citation Analysis]
7 Spiezia L, Campello E, Simion C, Poretto A, Dalla Valle F, Simioni P. Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants. Angiology. [DOI: 10.1177/00033197211070889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wik HS, Kahn SR, Eriksson H, Morrison D, Ghanima W, Schulman S, Sandset PM. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost 2021. [PMID: 34255420 DOI: 10.1111/jth.15449] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]